Keywords: alteplase, use, stroke, under, fire, again, genentech

Alteplase use in stroke under fire again

Article | 02 March 2000

Print This

Genentech's thrombolytic drug Activase (alteplase) was welcomed as anadvance when it became the first drug to be approved for ischemic ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in